nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—PTGS2—stomach cancer	0.511	1	CbGaD
Drospirenone—BCHE—Irinotecan—stomach cancer	0.0619	1	CbGbCtD
Drospirenone—BCHE—diaphragm—stomach cancer	0.0202	0.208	CbGeAlD
Drospirenone—Embolism—Floxuridine—stomach cancer	0.0098	0.066	CcSEcCtD
Drospirenone—Thromboembolic event—Irinotecan—stomach cancer	0.00796	0.0536	CcSEcCtD
Drospirenone—Cerebral infarction—Irinotecan—stomach cancer	0.00658	0.0443	CcSEcCtD
Drospirenone—PGR—blood vessel—stomach cancer	0.00612	0.0628	CbGeAlD
Drospirenone—Thromboembolic event—Docetaxel—stomach cancer	0.0055	0.037	CcSEcCtD
Drospirenone—Thromboembolic event—Capecitabine—stomach cancer	0.00533	0.0359	CcSEcCtD
Drospirenone—Infarction—Capecitabine—stomach cancer	0.00517	0.0348	CcSEcCtD
Drospirenone—Thromboembolic event—Methotrexate—stomach cancer	0.00397	0.0267	CcSEcCtD
Drospirenone—NR3C2—hematopoietic system—stomach cancer	0.0035	0.036	CbGeAlD
Drospirenone—Venous thromboembolism—Epirubicin—stomach cancer	0.0034	0.0229	CcSEcCtD
Drospirenone—Embolism—Irinotecan—stomach cancer	0.00334	0.0225	CcSEcCtD
Drospirenone—PGR—hematopoietic system—stomach cancer	0.00326	0.0335	CbGeAlD
Drospirenone—Haemoglobin—Floxuridine—stomach cancer	0.00317	0.0214	CcSEcCtD
Drospirenone—Haemorrhage—Floxuridine—stomach cancer	0.00316	0.0213	CcSEcCtD
Drospirenone—Venous thromboembolism—Doxorubicin—stomach cancer	0.00315	0.0212	CcSEcCtD
Drospirenone—NR3C2—smooth muscle tissue—stomach cancer	0.00309	0.0317	CbGeAlD
Drospirenone—PTGS2—blood vessel—stomach cancer	0.00305	0.0314	CbGeAlD
Drospirenone—Thrombosis—Irinotecan—stomach cancer	0.00303	0.0204	CcSEcCtD
Drospirenone—PGR—epithelium—stomach cancer	0.00298	0.0306	CbGeAlD
Drospirenone—PTGS2—gall bladder—stomach cancer	0.00287	0.0295	CbGeAlD
Drospirenone—PGR—smooth muscle tissue—stomach cancer	0.00287	0.0295	CbGeAlD
Drospirenone—AR—hematopoietic system—stomach cancer	0.00259	0.0267	CbGeAlD
Drospirenone—NR3C2—digestive system—stomach cancer	0.00244	0.025	CbGeAlD
Drospirenone—AR—epithelium—stomach cancer	0.00237	0.0244	CbGeAlD
Drospirenone—Loss of libido—Methotrexate—stomach cancer	0.00231	0.0156	CcSEcCtD
Drospirenone—Embolism—Docetaxel—stomach cancer	0.00231	0.0155	CcSEcCtD
Drospirenone—PGR—lymphoid tissue—stomach cancer	0.00229	0.0236	CbGeAlD
Drospirenone—AR—smooth muscle tissue—stomach cancer	0.00229	0.0235	CbGeAlD
Drospirenone—Embolism—Capecitabine—stomach cancer	0.00223	0.015	CcSEcCtD
Drospirenone—Nervous system disorder—Floxuridine—stomach cancer	0.0022	0.0148	CcSEcCtD
Drospirenone—BCHE—hematopoietic system—stomach cancer	0.00211	0.0217	CbGeAlD
Drospirenone—Thrombosis—Capecitabine—stomach cancer	0.00203	0.0136	CcSEcCtD
Drospirenone—NR3C2—endocrine gland—stomach cancer	0.00201	0.0207	CbGeAlD
Drospirenone—Embolism venous—Epirubicin—stomach cancer	0.00198	0.0133	CcSEcCtD
Drospirenone—PGR—endocrine gland—stomach cancer	0.00187	0.0192	CbGeAlD
Drospirenone—BCHE—smooth muscle tissue—stomach cancer	0.00186	0.0191	CbGeAlD
Drospirenone—Embolism venous—Doxorubicin—stomach cancer	0.00183	0.0123	CcSEcCtD
Drospirenone—AR—lymphoid tissue—stomach cancer	0.00183	0.0188	CbGeAlD
Drospirenone—NR3C2—liver—stomach cancer	0.00182	0.0186	CbGeAlD
Drospirenone—AR—digestive system—stomach cancer	0.0018	0.0185	CbGeAlD
Drospirenone—Embolism—Methotrexate—stomach cancer	0.00166	0.0112	CcSEcCtD
Drospirenone—PTGS2—hematopoietic system—stomach cancer	0.00163	0.0167	CbGeAlD
Drospirenone—Cerebrovascular accident—Irinotecan—stomach cancer	0.00159	0.0107	CcSEcCtD
Drospirenone—Embolism—Epirubicin—stomach cancer	0.00156	0.0105	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—AKR1C3—stomach cancer	0.00155	0.393	CrCbGaD
Drospirenone—AR—endocrine gland—stomach cancer	0.00149	0.0153	CbGeAlD
Drospirenone—PTGS2—epithelium—stomach cancer	0.00149	0.0153	CbGeAlD
Drospirenone—BCHE—digestive system—stomach cancer	0.00147	0.0151	CbGeAlD
Drospirenone—Embolism—Doxorubicin—stomach cancer	0.00144	0.0097	CcSEcCtD
Drospirenone—Hydrocortisone—ANXA1—stomach cancer	0.00143	0.364	CrCbGaD
Drospirenone—PTGS2—smooth muscle tissue—stomach cancer	0.00143	0.0147	CbGeAlD
Drospirenone—Thrombosis—Epirubicin—stomach cancer	0.00141	0.00951	CcSEcCtD
Drospirenone—NR3C2—lymph node—stomach cancer	0.00139	0.0143	CbGeAlD
Drospirenone—BCHE—bone marrow—stomach cancer	0.00135	0.0139	CbGeAlD
Drospirenone—AR—liver—stomach cancer	0.00134	0.0138	CbGeAlD
Drospirenone—Nausea—Floxuridine—stomach cancer	0.00133	0.00898	CcSEcCtD
Drospirenone—PTGS2—pancreas—stomach cancer	0.00132	0.0136	CbGeAlD
Drospirenone—Thrombosis—Doxorubicin—stomach cancer	0.00131	0.0088	CcSEcCtD
Drospirenone—PGR—lymph node—stomach cancer	0.00129	0.0133	CbGeAlD
Drospirenone—BCHE—endocrine gland—stomach cancer	0.00121	0.0125	CbGeAlD
Drospirenone—Acute coronary syndrome—Irinotecan—stomach cancer	0.00118	0.00796	CcSEcCtD
Drospirenone—Myocardial infarction—Irinotecan—stomach cancer	0.00118	0.00791	CcSEcCtD
Drospirenone—Breast pain—Epirubicin—stomach cancer	0.00115	0.00771	CcSEcCtD
Drospirenone—PTGS2—lymphoid tissue—stomach cancer	0.00115	0.0118	CbGeAlD
Drospirenone—Acute coronary syndrome—Fluorouracil—stomach cancer	0.00113	0.00762	CcSEcCtD
Drospirenone—PTGS2—digestive system—stomach cancer	0.00113	0.0116	CbGeAlD
Drospirenone—Myocardial infarction—Fluorouracil—stomach cancer	0.00113	0.00758	CcSEcCtD
Drospirenone—BCHE—liver—stomach cancer	0.00109	0.0112	CbGeAlD
Drospirenone—Haemoglobin—Irinotecan—stomach cancer	0.00108	0.00728	CcSEcCtD
Drospirenone—Haemorrhage—Irinotecan—stomach cancer	0.00108	0.00725	CcSEcCtD
Drospirenone—Cerebrovascular accident—Capecitabine—stomach cancer	0.00106	0.00716	CcSEcCtD
Drospirenone—Breast pain—Doxorubicin—stomach cancer	0.00106	0.00714	CcSEcCtD
Drospirenone—Migraine—Docetaxel—stomach cancer	0.00106	0.00713	CcSEcCtD
Drospirenone—Nausea—Mitomycin—stomach cancer	0.00105	0.00704	CcSEcCtD
Drospirenone—PTGS2—bone marrow—stomach cancer	0.00104	0.0107	CbGeAlD
Drospirenone—Haemoglobin—Fluorouracil—stomach cancer	0.00104	0.00698	CcSEcCtD
Drospirenone—Haemorrhage—Fluorouracil—stomach cancer	0.00103	0.00694	CcSEcCtD
Drospirenone—AR—lymph node—stomach cancer	0.00103	0.0106	CbGeAlD
Drospirenone—Migraine—Capecitabine—stomach cancer	0.00102	0.0069	CcSEcCtD
Drospirenone—Mood swings—Capecitabine—stomach cancer	0.000986	0.00664	CcSEcCtD
Drospirenone—Angiopathy—Irinotecan—stomach cancer	0.000977	0.00658	CcSEcCtD
Drospirenone—Breast disorder—Docetaxel—stomach cancer	0.000972	0.00654	CcSEcCtD
Drospirenone—Breast disorder—Capecitabine—stomach cancer	0.000941	0.00634	CcSEcCtD
Drospirenone—PTGS2—endocrine gland—stomach cancer	0.000935	0.0096	CbGeAlD
Drospirenone—PTGS2—liver—stomach cancer	0.000843	0.00865	CbGeAlD
Drospirenone—BCHE—lymph node—stomach cancer	0.000839	0.00861	CbGeAlD
Drospirenone—Acute coronary syndrome—Docetaxel—stomach cancer	0.000817	0.0055	CcSEcCtD
Drospirenone—Myocardial infarction—Docetaxel—stomach cancer	0.000812	0.00547	CcSEcCtD
Drospirenone—Depression—Capecitabine—stomach cancer	0.0008	0.00539	CcSEcCtD
Drospirenone—Acute coronary syndrome—Capecitabine—stomach cancer	0.000791	0.00533	CcSEcCtD
Drospirenone—Cerebrovascular accident—Methotrexate—stomach cancer	0.000791	0.00533	CcSEcCtD
Drospirenone—Myocardial infarction—Capecitabine—stomach cancer	0.000787	0.0053	CcSEcCtD
Drospirenone—Nervous system disorder—Irinotecan—stomach cancer	0.00075	0.00505	CcSEcCtD
Drospirenone—Haemoglobin—Docetaxel—stomach cancer	0.000748	0.00504	CcSEcCtD
Drospirenone—Haemorrhage—Docetaxel—stomach cancer	0.000744	0.00501	CcSEcCtD
Drospirenone—Cerebrovascular accident—Epirubicin—stomach cancer	0.00074	0.00499	CcSEcCtD
Drospirenone—Mood swings—Methotrexate—stomach cancer	0.000734	0.00495	CcSEcCtD
Drospirenone—Haemoglobin—Capecitabine—stomach cancer	0.000724	0.00488	CcSEcCtD
Drospirenone—Haemorrhage—Capecitabine—stomach cancer	0.00072	0.00485	CcSEcCtD
Drospirenone—Nervous system disorder—Fluorouracil—stomach cancer	0.000718	0.00484	CcSEcCtD
Drospirenone—Affect lability—Epirubicin—stomach cancer	0.000714	0.00481	CcSEcCtD
Drospirenone—Migraine—Epirubicin—stomach cancer	0.000714	0.00481	CcSEcCtD
Drospirenone—Erythema multiforme—Docetaxel—stomach cancer	0.000704	0.00474	CcSEcCtD
Drospirenone—Breast disorder—Methotrexate—stomach cancer	0.000701	0.00472	CcSEcCtD
Drospirenone—Mood swings—Epirubicin—stomach cancer	0.000687	0.00463	CcSEcCtD
Drospirenone—Cerebrovascular accident—Doxorubicin—stomach cancer	0.000685	0.00461	CcSEcCtD
Drospirenone—Erythema multiforme—Capecitabine—stomach cancer	0.000681	0.00459	CcSEcCtD
Drospirenone—Angiopathy—Docetaxel—stomach cancer	0.000675	0.00455	CcSEcCtD
Drospirenone—Migraine—Doxorubicin—stomach cancer	0.000661	0.00445	CcSEcCtD
Drospirenone—Affect lability—Doxorubicin—stomach cancer	0.000661	0.00445	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00066	0.00445	CcSEcCtD
Drospirenone—Breast disorder—Epirubicin—stomach cancer	0.000656	0.00441	CcSEcCtD
Drospirenone—Angiopathy—Capecitabine—stomach cancer	0.000654	0.0044	CcSEcCtD
Drospirenone—Mental disorder—Docetaxel—stomach cancer	0.000652	0.00439	CcSEcCtD
Drospirenone—PTGS2—lymph node—stomach cancer	0.000646	0.00664	CbGeAlD
Drospirenone—Mood swings—Doxorubicin—stomach cancer	0.000636	0.00428	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000632	0.00426	CcSEcCtD
Drospirenone—Mental disorder—Capecitabine—stomach cancer	0.000631	0.00425	CcSEcCtD
Drospirenone—Breast disorder—Doxorubicin—stomach cancer	0.000607	0.00408	CcSEcCtD
Drospirenone—Depression—Methotrexate—stomach cancer	0.000596	0.00401	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000548	0.00369	CcSEcCtD
Drospirenone—Haemoglobin—Methotrexate—stomach cancer	0.000539	0.00363	CcSEcCtD
Drospirenone—Haemorrhage—Methotrexate—stomach cancer	0.000536	0.00361	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00053	0.00357	CcSEcCtD
Drospirenone—Nervous system disorder—Docetaxel—stomach cancer	0.000518	0.00349	CcSEcCtD
Drospirenone—Skin disorder—Docetaxel—stomach cancer	0.000513	0.00346	CcSEcCtD
Drospirenone—Erythema multiforme—Methotrexate—stomach cancer	0.000507	0.00341	CcSEcCtD
Drospirenone—Haemoglobin—Epirubicin—stomach cancer	0.000504	0.0034	CcSEcCtD
Drospirenone—Nervous system disorder—Capecitabine—stomach cancer	0.000502	0.00338	CcSEcCtD
Drospirenone—Haemorrhage—Epirubicin—stomach cancer	0.000502	0.00338	CcSEcCtD
Drospirenone—Skin disorder—Capecitabine—stomach cancer	0.000497	0.00335	CcSEcCtD
Drospirenone—Angiopathy—Methotrexate—stomach cancer	0.000487	0.00328	CcSEcCtD
Drospirenone—Erythema multiforme—Epirubicin—stomach cancer	0.000475	0.0032	CcSEcCtD
Drospirenone—Mental disorder—Methotrexate—stomach cancer	0.00047	0.00316	CcSEcCtD
Drospirenone—Haemoglobin—Doxorubicin—stomach cancer	0.000467	0.00314	CcSEcCtD
Drospirenone—Haemorrhage—Doxorubicin—stomach cancer	0.000464	0.00313	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000456	0.00307	CcSEcCtD
Drospirenone—Angiopathy—Epirubicin—stomach cancer	0.000455	0.00307	CcSEcCtD
Drospirenone—Nausea—Irinotecan—stomach cancer	0.000454	0.00306	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000442	0.00298	CcSEcCtD
Drospirenone—Mental disorder—Epirubicin—stomach cancer	0.00044	0.00296	CcSEcCtD
Drospirenone—Erythema multiforme—Doxorubicin—stomach cancer	0.000439	0.00296	CcSEcCtD
Drospirenone—Nausea—Fluorouracil—stomach cancer	0.000435	0.00293	CcSEcCtD
Drospirenone—Angiopathy—Doxorubicin—stomach cancer	0.000421	0.00284	CcSEcCtD
Drospirenone—Mental disorder—Doxorubicin—stomach cancer	0.000407	0.00274	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000395	0.00266	CcSEcCtD
Drospirenone—Nervous system disorder—Methotrexate—stomach cancer	0.000374	0.00252	CcSEcCtD
Drospirenone—Skin disorder—Methotrexate—stomach cancer	0.00037	0.00249	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000369	0.00249	CcSEcCtD
Drospirenone—Progesterone—CYP2A6—stomach cancer	0.000359	0.0909	CrCbGaD
Drospirenone—Nervous system disorder—Epirubicin—stomach cancer	0.00035	0.00235	CcSEcCtD
Drospirenone—Skin disorder—Epirubicin—stomach cancer	0.000346	0.00233	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000342	0.0023	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000329	0.00222	CcSEcCtD
Drospirenone—Nervous system disorder—Doxorubicin—stomach cancer	0.000324	0.00218	CcSEcCtD
Drospirenone—Skin disorder—Doxorubicin—stomach cancer	0.00032	0.00216	CcSEcCtD
Drospirenone—Nausea—Docetaxel—stomach cancer	0.000314	0.00211	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000308	0.00207	CcSEcCtD
Drospirenone—Nausea—Capecitabine—stomach cancer	0.000304	0.00205	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000285	0.00192	CcSEcCtD
Drospirenone—Norethindrone—ALB—stomach cancer	0.00024	0.0609	CrCbGaD
Drospirenone—Methyltestosterone—ALB—stomach cancer	0.000228	0.0578	CrCbGaD
Drospirenone—Nausea—Methotrexate—stomach cancer	0.000226	0.00152	CcSEcCtD
Drospirenone—Nausea—Epirubicin—stomach cancer	0.000212	0.00143	CcSEcCtD
Drospirenone—Nausea—Doxorubicin—stomach cancer	0.000196	0.00132	CcSEcCtD
Drospirenone—Testosterone—ALB—stomach cancer	0.000132	0.0335	CrCbGaD
Drospirenone—PGR—Signaling Pathways—GAST—stomach cancer	7.96e-05	0.000448	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALDH7A1—stomach cancer	7.9e-05	0.000445	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PLCE1—stomach cancer	7.9e-05	0.000445	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	7.78e-05	0.000438	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—TNF—stomach cancer	7.74e-05	0.000436	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—TP53—stomach cancer	7.71e-05	0.000434	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—RPS6—stomach cancer	7.66e-05	0.000431	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FBP1—stomach cancer	7.64e-05	0.00043	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	7.61e-05	0.000429	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	7.61e-05	0.000428	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—ACE—stomach cancer	7.6e-05	0.000428	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—UMPS—stomach cancer	7.57e-05	0.000427	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	7.57e-05	0.000426	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGG—stomach cancer	7.54e-05	0.000425	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PGLS—stomach cancer	7.52e-05	0.000424	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—BLVRB—stomach cancer	7.52e-05	0.000424	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRKAA1—stomach cancer	7.26e-05	0.000409	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	7.25e-05	0.000408	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	7.19e-05	0.000405	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPAP2A—stomach cancer	7.18e-05	0.000404	CbGpPWpGaD
Drospirenone—BCHE—Phospholipid metabolism—PIK3CA—stomach cancer	7.15e-05	0.000403	CbGpPWpGaD
Drospirenone—AR—Gene Expression—HSPB1—stomach cancer	7.07e-05	0.000398	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ECHS1—stomach cancer	7.04e-05	0.000397	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PDHA1—stomach cancer	7.04e-05	0.000397	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PPARG—stomach cancer	7.03e-05	0.000396	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RBP4—stomach cancer	7.01e-05	0.000395	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	6.9e-05	0.000389	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL6—stomach cancer	6.87e-05	0.000387	CbGpPWpGaD
Drospirenone—AR—Gene Expression—RPS19—stomach cancer	6.87e-05	0.000387	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PGAM1—stomach cancer	6.81e-05	0.000383	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PPARG—stomach cancer	6.78e-05	0.000382	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—HRAS—stomach cancer	6.78e-05	0.000382	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MAPK3—stomach cancer	6.76e-05	0.000381	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PPP2R1A—stomach cancer	6.63e-05	0.000373	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TYMP—stomach cancer	6.62e-05	0.000373	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—FADS1—stomach cancer	6.62e-05	0.000373	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	6.6e-05	0.000372	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MYC—stomach cancer	6.57e-05	0.00037	CbGpPWpGaD
Drospirenone—AR—Gene Expression—DNMT1—stomach cancer	6.57e-05	0.00037	CbGpPWpGaD
Drospirenone—PTGS2—Disease—WIF1—stomach cancer	6.49e-05	0.000366	CbGpPWpGaD
Drospirenone—AR—Gene Expression—HSPA8—stomach cancer	6.48e-05	0.000365	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MAPK1—stomach cancer	6.43e-05	0.000362	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—EGFR—stomach cancer	6.43e-05	0.000362	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CKB—stomach cancer	6.4e-05	0.00036	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CA1—stomach cancer	6.4e-05	0.00036	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NDUFA2—stomach cancer	6.4e-05	0.00036	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—FBP1—stomach cancer	6.4e-05	0.00036	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	6.39e-05	0.00036	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—SERPINE1—stomach cancer	6.33e-05	0.000357	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	6.31e-05	0.000355	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL6—stomach cancer	6.25e-05	0.000352	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SREBF2—stomach cancer	6.2e-05	0.000349	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SMAD4—stomach cancer	6.16e-05	0.000347	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—MAPK1—stomach cancer	6.13e-05	0.000345	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—RORA—stomach cancer	6.13e-05	0.000345	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNF—stomach cancer	6.12e-05	0.000345	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—SERPINE1—stomach cancer	6.11e-05	0.000344	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RPL13—stomach cancer	6.11e-05	0.000344	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RPL18—stomach cancer	6.11e-05	0.000344	CbGpPWpGaD
Drospirenone—AR—Gene Expression—RPS6—stomach cancer	6.08e-05	0.000342	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AGTR2—stomach cancer	6.03e-05	0.00034	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HSPB1—stomach cancer	6.03e-05	0.00034	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PLIN2—stomach cancer	6.01e-05	0.000339	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—BMP2—stomach cancer	5.96e-05	0.000336	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—F2R—stomach cancer	5.96e-05	0.000336	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKR1C3—stomach cancer	5.87e-05	0.00033	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CA2—stomach cancer	5.85e-05	0.000329	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	5.84e-05	0.000329	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR1A—stomach cancer	5.8e-05	0.000327	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RNF43—stomach cancer	5.79e-05	0.000326	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALDOB—stomach cancer	5.74e-05	0.000323	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PGAM1—stomach cancer	5.7e-05	0.000321	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NT5E—stomach cancer	5.7e-05	0.000321	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RPS15—stomach cancer	5.69e-05	0.000321	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RPS21—stomach cancer	5.69e-05	0.000321	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—ERCC2—stomach cancer	5.62e-05	0.000316	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ANXA1—stomach cancer	5.61e-05	0.000316	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	5.58e-05	0.000314	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	5.56e-05	0.000313	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALDH7A1—stomach cancer	5.44e-05	0.000306	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PLCE1—stomach cancer	5.44e-05	0.000306	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADRB1—stomach cancer	5.43e-05	0.000306	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	5.41e-05	0.000305	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	5.4e-05	0.000304	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TP53—stomach cancer	5.4e-05	0.000304	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	5.39e-05	0.000304	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALOX5—stomach cancer	5.34e-05	0.000301	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	5.26e-05	0.000296	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—DPYD—stomach cancer	5.25e-05	0.000296	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—UMPS—stomach cancer	5.21e-05	0.000294	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RPS6—stomach cancer	5.19e-05	0.000292	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—MYC—stomach cancer	5.07e-05	0.000286	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPP2R1A—stomach cancer	5.05e-05	0.000284	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL6—stomach cancer	4.94e-05	0.000278	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—HRAS—stomach cancer	4.92e-05	0.000277	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	4.86e-05	0.000274	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PDHA1—stomach cancer	4.85e-05	0.000273	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ECHS1—stomach cancer	4.85e-05	0.000273	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HBEGF—stomach cancer	4.77e-05	0.000268	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.76e-05	0.000268	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ALDOB—stomach cancer	4.72e-05	0.000266	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—MAPK1—stomach cancer	4.69e-05	0.000264	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SMAD4—stomach cancer	4.69e-05	0.000264	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTT1—stomach cancer	4.64e-05	0.000261	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RPL15—stomach cancer	4.63e-05	0.000261	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	4.6e-05	0.000259	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP2A6—stomach cancer	4.59e-05	0.000258	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—FADS1—stomach cancer	4.56e-05	0.000257	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TYMP—stomach cancer	4.56e-05	0.000257	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NPM1—stomach cancer	4.54e-05	0.000256	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	4.47e-05	0.000252	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKR1C3—stomach cancer	4.46e-05	0.000251	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADRB2—stomach cancer	4.4e-05	0.000248	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RBP4—stomach cancer	4.39e-05	0.000247	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	4.38e-05	0.000246	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	4.37e-05	0.000246	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ENO1—stomach cancer	4.35e-05	0.000245	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RPS26—stomach cancer	4.32e-05	0.000243	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PPP2R1A—stomach cancer	4.31e-05	0.000243	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PPARG—stomach cancer	4.28e-05	0.000241	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PPIA—stomach cancer	4.28e-05	0.000241	CbGpPWpGaD
Drospirenone—AR—Gene Expression—ERCC2—stomach cancer	4.28e-05	0.000241	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.28e-05	0.000241	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SREBF2—stomach cancer	4.27e-05	0.00024	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—RORA—stomach cancer	4.22e-05	0.000237	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	4.17e-05	0.000235	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	4.13e-05	0.000233	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MAPK3—stomach cancer	4.12e-05	0.000232	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MYC—stomach cancer	4.01e-05	0.000226	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SMAD4—stomach cancer	4e-05	0.000225	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALDOB—stomach cancer	3.95e-05	0.000223	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—MYC—stomach cancer	3.86e-05	0.000218	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CD44—stomach cancer	3.86e-05	0.000217	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SERPINE1—stomach cancer	3.86e-05	0.000217	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FYN—stomach cancer	3.8e-05	0.000214	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	3.8e-05	0.000214	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP2—stomach cancer	3.78e-05	0.000213	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—HRAS—stomach cancer	3.77e-05	0.000212	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.74e-05	0.000211	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.73e-05	0.00021	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.72e-05	0.000209	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALOX5—stomach cancer	3.67e-05	0.000207	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.67e-05	0.000207	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKR1C3—stomach cancer	3.67e-05	0.000207	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RPS19—stomach cancer	3.67e-05	0.000207	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—DPYD—stomach cancer	3.61e-05	0.000204	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ENO1—stomach cancer	3.58e-05	0.000201	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGFR2—stomach cancer	3.57e-05	0.000201	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPP2R1A—stomach cancer	3.28e-05	0.000185	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.28e-05	0.000184	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IRS2—stomach cancer	3.27e-05	0.000184	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARG—stomach cancer	3.26e-05	0.000184	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RPS6—stomach cancer	3.24e-05	0.000183	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTP1—stomach cancer	3.22e-05	0.000181	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTT1—stomach cancer	3.2e-05	0.00018	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HMOX1—stomach cancer	3.17e-05	0.000179	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD44—stomach cancer	3.17e-05	0.000179	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CAV1—stomach cancer	3.17e-05	0.000178	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APOA1—stomach cancer	3.16e-05	0.000178	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP2A6—stomach cancer	3.16e-05	0.000178	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CXCL8—stomach cancer	3.14e-05	0.000177	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKR1C3—stomach cancer	3.07e-05	0.000173	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRKCB—stomach cancer	3.01e-05	0.00017	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6ST—stomach cancer	3e-05	0.000169	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ENO1—stomach cancer	2.99e-05	0.000169	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TYMS—stomach cancer	2.99e-05	0.000168	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HBEGF—stomach cancer	2.98e-05	0.000168	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTM1—stomach cancer	2.96e-05	0.000167	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.95e-05	0.000166	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SERPINE1—stomach cancer	2.94e-05	0.000166	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APC—stomach cancer	2.89e-05	0.000162	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ERCC2—stomach cancer	2.78e-05	0.000157	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PPP2R1A—stomach cancer	2.7e-05	0.000152	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6R—stomach cancer	2.68e-05	0.000151	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CD44—stomach cancer	2.66e-05	0.00015	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—MTHFR—stomach cancer	2.61e-05	0.000147	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MAPK3—stomach cancer	2.51e-05	0.000141	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SERPINE1—stomach cancer	2.51e-05	0.000141	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SMAD4—stomach cancer	2.5e-05	0.000141	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MYC—stomach cancer	2.44e-05	0.000137	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RHOA—stomach cancer	2.42e-05	0.000136	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CAV1—stomach cancer	2.41e-05	0.000136	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APOA1—stomach cancer	2.41e-05	0.000135	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOS3—stomach cancer	2.39e-05	0.000135	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FYN—stomach cancer	2.38e-05	0.000134	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.3e-05	0.00013	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERCC2—stomach cancer	2.29e-05	0.000129	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPP2R1A—stomach cancer	2.26e-05	0.000127	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ERBB2—stomach cancer	2.24e-05	0.000126	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGFR2—stomach cancer	2.23e-05	0.000126	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTP1—stomach cancer	2.22e-05	0.000125	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HMOX1—stomach cancer	2.18e-05	0.000123	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTHFR—stomach cancer	2.15e-05	0.000121	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL8—stomach cancer	2.12e-05	0.00012	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARG—stomach cancer	2.12e-05	0.000119	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1B—stomach cancer	2.07e-05	0.000117	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TYMS—stomach cancer	2.06e-05	0.000116	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IRS2—stomach cancer	2.04e-05	0.000115	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTM1—stomach cancer	2.04e-05	0.000115	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CAV1—stomach cancer	1.98e-05	0.000112	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCND1—stomach cancer	1.98e-05	0.000111	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APOA1—stomach cancer	1.98e-05	0.000111	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JUN—stomach cancer	1.98e-05	0.000111	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—stomach cancer	1.92e-05	0.000108	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1A—stomach cancer	1.91e-05	0.000108	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ERCC2—stomach cancer	1.91e-05	0.000108	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MAPK3—stomach cancer	1.91e-05	0.000108	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALB—stomach cancer	1.91e-05	0.000107	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6ST—stomach cancer	1.88e-05	0.000106	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK8—stomach cancer	1.87e-05	0.000105	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MYC—stomach cancer	1.86e-05	0.000105	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NOS3—stomach cancer	1.82e-05	0.000103	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APC—stomach cancer	1.8e-05	0.000102	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MTHFR—stomach cancer	1.8e-05	0.000101	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—stomach cancer	1.73e-05	9.72e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STAT3—stomach cancer	1.71e-05	9.62e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6R—stomach cancer	1.68e-05	9.44e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—stomach cancer	1.67e-05	9.39e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CAV1—stomach cancer	1.66e-05	9.34e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOA1—stomach cancer	1.66e-05	9.32e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK3—stomach cancer	1.63e-05	9.19e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MYC—stomach cancer	1.59e-05	8.94e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.59e-05	8.93e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SERPINE1—stomach cancer	1.57e-05	8.84e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK1—stomach cancer	1.55e-05	8.75e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGFR—stomach cancer	1.55e-05	8.74e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RHOA—stomach cancer	1.51e-05	8.52e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS3—stomach cancer	1.5e-05	8.44e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KRAS—stomach cancer	1.47e-05	8.26e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARG—stomach cancer	1.46e-05	8.21e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERBB2—stomach cancer	1.4e-05	7.89e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CA—stomach cancer	1.35e-05	7.59e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALB—stomach cancer	1.31e-05	7.39e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—stomach cancer	1.3e-05	7.34e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1B—stomach cancer	1.3e-05	7.31e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NOS3—stomach cancer	1.25e-05	7.07e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HRAS—stomach cancer	1.25e-05	7.02e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1A—stomach cancer	1.2e-05	6.74e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—stomach cancer	1.19e-05	6.72e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT3—stomach cancer	1.07e-05	6.02e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CA—stomach cancer	1.03e-05	5.78e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAPK3—stomach cancer	1.02e-05	5.75e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MYC—stomach cancer	9.93e-06	5.59e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAPK1—stomach cancer	9.72e-06	5.47e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGFR—stomach cancer	9.71e-06	5.47e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KRAS—stomach cancer	9.18e-06	5.17e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CA—stomach cancer	8.43e-06	4.75e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HRAS—stomach cancer	7.8e-06	4.39e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—stomach cancer	7.47e-06	4.2e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CA—stomach cancer	7.06e-06	3.98e-05	CbGpPWpGaD
